News Related to EPHA2

Related coverage linked through entity extraction aliases.

Antibody-Based Cancer Therapies Show Promise in Breast Cancer, Imaging, and Lymphoma

Mar 19, 2026

New antibody-based approaches demonstrate clinical benefits across multiple cancer types, including improved survival in triple-negative breast cancer, enhanced tumor detection via PET imaging, and activity in relapsed mantle cell lymphoma.

New Cancer Research Shows Promise in Blood Cancer, Prostate Cancer, and Ovarian Cancer Treatment

Mar 17, 2026

Recent studies demonstrate high response rates for antibody-drug conjugate in rare blood cancer, improved outcomes with metastasis-directed radiation in prostate cancer, and a novel drug combination strategy for ovarian cancer resistance.